Civic Intelligence

Confometrx Research Foundation

EIN 27-0802325 • 501(c)3 • Palo Alto, CA

Pub. 78 Eligible

Profile

The specific purpose of the foundation is to bring together scientists from academia, biotechnology and pharmaceutical industry to exchange ideas, disseminate information, and discuss challenges related to drug development for g-protein coupled receptors in order to facilitate the discovery of more effective and selective therapeutics for unmet medical needs.

840 Chimalus DrivePalo Alto, CA 94306

www.gpcrworkshop.com

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

60th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

501(c)3 • <$500k nonprofits • Source year 2024

Liabilities / Revenue

Score unavailable

No value available

Liabilities-to-revenue requires both liabilities and revenue on the latest valid filing.

Source year 2024

Net Margin

Score unavailable

No value available

Net margin requires both revenue and expenses on the latest valid filing.

Source year 2024

Top Officer Pay

81st percentile

$0

Higher top officer pay than 81% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2024

Asset Growth

47th percentile

-3.7%

Faster asset growth than 47% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2023 to 2024

Revenue Growth

3rd percentile

-100%

Faster revenue growth than 3% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2023 to 2024

Assets

Down

$77,594

Down $2,972 (-3.7%) from 2023

Liabilities

Flat

$0

Flat from 2023

Net Assets

Down

$77,594

Down $2,972 (-3.7%) from 2023

Revenue

Down

$0

Down $20,000 (-100%) from 2023

Expenses

Down

$2,972

Down $118,142 (-98%) from 2023

Net Income

Up

-$2,972

Up $98,142 (+97%) from 2023

Trend Graphs

Balance Sheet Trend

Grouped bars show assets, liabilities, and net assets across loaded filings.

$200K$150K$100K$50K$0Assets 2010: $24,367Liabilities 2010: $0Net Assets 2010: $24,3672010Assets 2011: $38,854Liabilities 2011: $0Net Assets 2011: $38,8542011Assets 2012: $30,265Liabilities 2012: $0Net Assets 2012: $30,2652012Assets 2015: $81,863Liabilities 2015: $0Net Assets 2015: $81,8632015Assets 2016: $52,357Liabilities 2016: $0Net Assets 2016: $52,3572016Assets 2017: $119,373Liabilities 2017: $0Net Assets 2017: $119,3732017Assets 2018: $44,828Liabilities 2018: $0Net Assets 2018: $44,8282018Assets 2019: $47,887Liabilities 2019: $0Net Assets 2019: $47,8872019Assets 2020: $43,977Liabilities 2020: $0Net Assets 2020: $43,9772020Assets 2021: $41,631Liabilities 2021: $0Net Assets 2021: $41,6312021Assets 2022: $181,680Liabilities 2022: $0Net Assets 2022: $181,6802022Assets 2023: $80,566Liabilities 2023: $0Net Assets 2023: $80,5662023Assets 2024: $77,594Liabilities 2024: $0Net Assets 2024: $77,5942024

Highlighted filing

2024

Assets$77,594
Liabilities$0
Net Assets$77,594

Operations Trend

Revenue, expenses, and net income by year, with the latest filing highlighted.

$200K$100K$0-$100K-$200KRevenue 2010: $94,573Expenses 2010: $90,206Net Income 2010: $4,3672010Revenue 2011: $153,455Expenses 2011: $138,968Net Income 2011: $14,4872011Revenue 2012: $1,000Expenses 2012: $9,589Net Income 2012: -$8,5892012Revenue 2015: $161,380Expenses 2015: $137,031Net Income 2015: $24,3492015Revenue 2016: $5,000Expenses 2016: $4,506Net Income 2016: $4942016Revenue 2017: $168,670Expenses 2017: $101,654Net Income 2017: $67,0162017Revenue 2018: $0Expenses 2018: $74,545Net Income 2018: -$74,5452018Revenue 2019: $187,956Expenses 2019: $184,897Net Income 2019: $3,0592019Revenue 2020: $1,735Expenses 2020: $5,645Net Income 2020: -$3,9102020Revenue 2021: $0Expenses 2021: $2,346Net Income 2021: -$2,3462021Revenue 2022: $156,201Expenses 2022: $16,152Net Income 2022: $140,0492022Revenue 2023: $20,000Expenses 2023: $121,114Net Income 2023: -$101,1142023Revenue 2024: $0Expenses 2024: $2,972Net Income 2024: -$2,9722024

Highlighted filing

2024

Revenue$0
Expenses$2,972
Net Income-$2,972

Filings

Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Detailed filing. Detailed filing data is available for this year.$0.78$0.00$0.78$0.00$0.03$0.03
2023Detailed filing. Detailed filing data is available for this year.$0.81$0.00$0.81$0.20$1.21$1.01
2022Detailed filing. Detailed filing data is available for this year.$1.82$0.00$1.82$1.56$0.16$1.40
2021Detailed filing. Detailed filing data is available for this year.$0.42$0.00$0.42$0.00$0.02$0.02
2020Detailed filing. Detailed filing data is available for this year.$0.44$0.00$0.44$0.02$0.06$0.04
2019Detailed filing. Detailed filing data is available for this year.$0.48$0.00$0.48$1.88$1.85$0.03
2018Detailed filing. Detailed filing data is available for this year.$0.45$0.00$0.45$0.00$0.75$0.75
2017Detailed filing. Detailed filing data is available for this year.$1.19$0.00$1.19$1.69$1.02$0.67
2016Detailed filing. Detailed filing data is available for this year.$0.52$0.00$0.52$0.05$0.05$0.00
2015Detailed filing. Detailed filing data is available for this year.$0.82$0.00$0.82$1.61$1.37$0.24
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.30$0.00$0.30$0.01$0.10$0.09
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.39$0.00$0.39$1.53$1.39$0.14
2010Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.24$0.00$0.24$0.95$0.90$0.04
Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Jan 1, 2024 to Dec 31, 2024
Signed
May 12, 2025
Return Version
2024v5.1
Gross Receipts
$0
Mission and Program Overview

Mission

The specific purpose of the foundation is to bring together scientists from academia, biotechnology and pharmaceutical industry to exchange ideas, disseminate information, and discuss challenges related to drug development for g-protein coupled receptors in order to facilitate the discovery of more effective and selective therapeutics for unmet medical needs.

Program Services

DescriptionGrantsExpenses
PROGRAM SERVICE ACCOMPLISHMENT 1CONFERENCE HELD IN HAWAII FOR SCIENTISTS FROM ACADEMIA, BIOTECHNOLOGY, AND PHARMACEUTICAL INDUSTRY AND STUDENTS TO FACILITATE PROGRESS IN UNDERSTANDING OF HOW GPCRS WORK AT A CELLULAR AND MOLECULAR LEVEL SO AS TO FACILITATE THE DEVELOPMENT OF MORE EFFECTIVE THERAPEUTICS FOR GPCR TARGETS.$0$0
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
TONG SUN KOBILKAPresident/DirectorPT$0--
BRIAN KOBILKAVice PresidentPT$0--
Filing and Contact Details

Filer

Filer Name
Confometrx Research Foundation
EIN
27-0802325
Phone
6505754162
Address
840 CHIMALUS DRIVE, PALO ALTO, CA 94306

Signing Officer

Name
Tong Sun Kobilka
Title
President
Phone
6505754162
Signed
2025-05-12
Discuss with paid preparer
No

Preparer

Firm
Klh & Associates
Address
7901 STONERIDGE DRIVE SUITE 109, PLEASANTON, CA 94588
Preparer
David Lau
Phone
9259489696
Supplemental Narrative

Additional Explanations

Form 990-ez, Part II, Line 24 - Other Assets

Description: deposit - waikoloa marriott hotel. Beg. Of year amount: 0. End of year amount: 5,000.

Raw XML Appendix129 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd00
IRS990EZ/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0TONG SUN KOBILKA
IRS990EZ/BooksInCareOfDetail/PhoneNum06505754162
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt0840 CHIMALUS DRIVE
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0PALO ALTO
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CA
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd094306
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt080566
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt072594
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd00
IRS990EZ/DirectIndirectPltclExpendAmt00
IRS990EZ/DonorAdvisedFndsInd00
IRS990EZ/EngagedInExcessBenefitTransInd00
IRS990EZ/ExcessOrDeficitForYearAmt0-2972
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt02972
IRS990EZ/FiledScheduleAInd01
IRS990EZ/ForeignFinancialAccountInd00
IRS990EZ/ForeignOfficeInd00
IRS990EZ/Form990TotalAssetsGrp/BOYAmt080566
IRS990EZ/Form990TotalAssetsGrp/EOYAmt077594
IRS990EZ/GrossReceiptsAmt00
IRS990EZ/InfoInScheduleOPartIIIInd0X
IRS990EZ/InfoInScheduleOPartIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/InfoInScheduleOPartVInd0X
IRS990EZ/LobbyingActivitiesInd00
IRS990EZ/MadeLoansToFromOfficersInd00
IRS990EZ/MethodOfAccountingCashInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt080566
IRS990EZ/NetAssetsOrFundBalancesEOYAmt077594
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt080566
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt077594
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt010.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt15.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0TONG SUN KOBILKA
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1BRIAN KOBILKA
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0PRESIDENT/DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1VICE PRESIDENT
IRS990EZ/OperateHospitalInd00
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd00
IRS990EZ/OrganizationHadUBIInd00
IRS990EZ/OtherAssetsTotalDetail/BOYAmt00
IRS990EZ/OtherAssetsTotalDetail/EOYAmt05000
IRS990EZ/OtherChangesInNetAssetsAmt00
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd00
IRS990EZ/PrimaryExemptPurposeTxt0THE SPECIFIC PURPOSE OF THE FOUNDATION IS TO BRING TOGETHER SCIENTISTS FROM ACADEMIA, BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRY TO EXCHANGE IDEAS, DISSEMINATE INFORMATION, AND DISCUSS CHALLENGES RELATED TO DRUG DEVELOPMENT FOR G-PROTEIN COUPLED RECEPTORS IN ORDER TO FACILITATE THE DISCOVERY OF MORE EFFECTIVE AND SELECTIVE THERAPEUTICS FOR UNMET MEDICAL NEEDS.
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0PROGRAM SERVICE ACCOMPLISHMENT 1CONFERENCE HELD IN HAWAII FOR SCIENTISTS FROM ACADEMIA, BIOTECHNOLOGY, AND PHARMACEUTICAL INDUSTRY AND STUDENTS TO FACILITATE PROGRESS IN UNDERSTANDING OF HOW GPCRS WORK AT A CELLULAR AND MOLECULAR LEVEL SO AS TO FACILITATE THE DEVELOPMENT OF MORE EFFECTIVE THERAPEUTICS FOR GPCR TARGETS.
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt00
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt00
IRS990EZ/ProhibitedTaxShelterTransInd00
IRS990EZ/RelatedOrganizationCtrlEntInd00
IRS990EZ/ScheduleBNotRequiredInd0X
IRS990EZ/SchoolOperatingInd00
IRS990EZ/StatesWhereCopyOfReturnIsFldCd0CA
IRS990EZ/SubjectToProxyTaxInd00
IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt00
IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt00
IRS990EZ/TanningServicesProvidedInd00
IRS990EZ/TaxImposedOnOrganizationMgrAmt00
IRS990EZ/TaxImposedUnderIRC4911Amt00
IRS990EZ/TaxImposedUnderIRC4912Amt00
IRS990EZ/TaxImposedUnderIRC4955Amt00
IRS990EZ/TaxReimbursedByOrganizationAmt00
IRS990EZ/TotalExpensesAmt02972
IRS990EZ/TotalProgramServiceExpensesAmt00
IRS990EZ/TotalRevenueAmt00
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd00
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0HTTP://WWW.GPCRWORKSHOP.COM/
IRS990ScheduleA/AmountsRcvdDsqlfyPersonGrp/TotalAmt00
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt020000
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus2YearsAmt093250
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt0113250
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus2YearsAmt062951
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/TotalAmt062951
IRS990ScheduleA/InvestmentIncomeCYPct00.00000
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportCY509Pct01.00000
IRS990ScheduleA/PublicSupportPY509Pct01.00000
IRS990ScheduleA/PublicSupportTotal509Amt0176201
IRS990ScheduleA/SubstAndDsqlfyPrsnsTotGrp/TotalAmt00
IRS990ScheduleA/SubstantialContributorsAmtGrp/TotalAmt00
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind0X
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt020000
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt0156201
IRS990ScheduleA/Total509Grp/TotalAmt0176201
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt020000
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt0156201
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt0176201
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0DESCRIPTION: DEPOSIT - WAIKOLOA MARRIOTT HOTEL. BEG. OF YEAR AMOUNT: 0. END OF YEAR AMOUNT: 5,000.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990-EZ, PART II, LINE 24 - OTHER ASSETS
TransferPrsnlBnftContractsDecl/DeclarationDesc0THE ORGANIZATION DID NOT, DURING THE YEAR, RECEIVE ANY FUNDS, DIRECTLY,OR INDIRECTLY, TO PAY PREMIUMS ON A PERSONAL BENEFIT CONTRACT.THE ORGANIZATION, DID NOT, DURING THE YEAR, PAY ANY PREMIUMS, DIRECTLY,OR INDIRECTLY, ON A PERSONAL BENEFIT CONTRACT.
ReturnHeader/BuildTS02025-03-06 01:10:19Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd00
ReturnHeader/BusinessOfficerGrp/PersonNm0TONG SUN KOBILKA
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0PRESIDENT
ReturnHeader/BusinessOfficerGrp/PhoneNum06505754162
ReturnHeader/BusinessOfficerGrp/SignatureDt02025-05-12
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0CONFOMETRX RESEARCH FOUNDATION
ReturnHeader/Filer/BusinessNameControlTxt0CONF
ReturnHeader/Filer/EIN0270802325
ReturnHeader/Filer/PhoneNum06505754162
ReturnHeader/Filer/USAddress/AddressLine1Txt0840 CHIMALUS DRIVE
ReturnHeader/Filer/USAddress/CityNm0PALO ALTO
ReturnHeader/Filer/USAddress/StateAbbreviationCd0CA
ReturnHeader/Filer/USAddress/ZIPCd094306
ReturnHeader/IRSResponsiblePrtyInfoCurrInd00
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0814816968
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0KLH & ASSOCIATES
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt07901 STONERIDGE DRIVE SUITE 109
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0PLEASANTON
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0CA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd094588
ReturnHeader/PreparerPersonGrp/PhoneNum09259489696
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0DAVID LAU
ReturnHeader/ReturnTs02025-05-13T19:47:38-05:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02024-01-01
ReturnHeader/TaxPeriodEndDt02024-12-31
ReturnHeader/TaxYr02024

Document Assets

No mirrored PDF or thumbnail assets are attached yet.